Literature DB >> 7723405

Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case-control study.

C Nisse1, C Lorthois, V Dorp, E Eloy, J M Haguenoer, P Fenaux.   

Abstract

We performed a case-control study of occupational and environmental risk factors in myelodysplastic syndromes (MDS) diagnosed at our institution, using the method of Siemiatycki. A control for each MDS case, matched for age, sex, and residence area was chosen. The questionnaire asked demographic data, medical history, and information on life-time environmental and occupational exposures. Occupational exposures were first assessed by job titles, then by evaluating exposure to a list of 70 chemicals, and the level and duration of exposure to those chemicals (exposure index). In the first 100 cases and controls analyzed, a significantly higher incidence of smokers or ex-smokers was seen in MDS cases (odds ratio, OR = 1.83, P = 0.03). A significant excess of MDS was found in male patients with jobs (or previous jobs) generally exposing to chemical compounds, including plant and machine operators and assemblers (odds ratio, OR = 3.73, P = 0.014) whereas, on the contrary, technicians and associate professionals were more often seen in controls (OR = 0.17, P = 0.002). In males, there was also a trend for more skilled agricultural workers and coal miners in MDS cases. In females, there was a non-significant trend for more professionals in controls. After adjusting for sex, age and smoking habits, significantly more frequent exposure to stone dusts (OR = 3.06, P = 0.011), and cereal dusts (OR = 2.27, P = 0.04) was found. There was also a trend for higher incidence of exposure to exhaust gases and nitro-organic explosives. In addition, significantly higher exposure indices to petrol and diesel derivatives (P = 0.03) and to fertilizers (P = 0.003) were seen in MDS cases, as compared to controls. No significant difference in exposure to other chemicals was seen between MDS cases and controls. These preliminary results of our study, which is accruing more cases, suggest, as two previously published case-control studies of risk factors in MDS, that exposure to some chemicals may be involved in the pathogenesis of MDS.

Entities:  

Mesh:

Year:  1995        PMID: 7723405

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

Review 1.  Chromosome and molecular abnormalities in myelodysplastic syndromes.

Authors:  Pierre Fenaux
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

Review 2.  Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statistics.

Authors:  C Aul; A Giagounidis; U Germing
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

3.  Alcohol use is not a significant contributor to myelodysplastic syndromes.

Authors:  Elizabeth A Duffy; Phuong L Nguyen; Adina Cioc; Erica Warlick; Michelle A Roesler; Jenny N Poynter
Journal:  Cancer Causes Control       Date:  2020-04-13       Impact factor: 2.506

4.  Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort.

Authors:  Xiaomei Ma; Unhee Lim; Yikyung Park; Susan T Mayne; Rong Wang; Patricia Hartge; Albert R Hollenbeck; Arthur Schatzkin
Journal:  Am J Epidemiol       Date:  2009-04-24       Impact factor: 4.897

Review 5.  Hematological malignancies in chronic inflammatory bowel diseases: report of five cases and review of the literature.

Authors:  Pietro Crispino; Roberta Pica; Erika Angelucci; Adriana Consolazio; Margherita Rivera; Claudio Cassieri; Paolo Paoluzi
Journal:  Int J Colorectal Dis       Date:  2006-10-07       Impact factor: 2.796

6.  Asthma and risk of myelodysplastic syndromes: a population-based cohort study.

Authors:  Henrik Frederiksen; Dóra Körmendiné Farkas; Erzsébet Horváth-Puhó; Jan M Nørgaard; Mette Nørgaard; Henrik T Sørensen
Journal:  Br J Cancer       Date:  2016-11-29       Impact factor: 7.640

7.  Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS).

Authors:  Rina Yarosh; Michelle A Roesler; Thomas Murray; Adina Cioc; Betsy Hirsch; Phuong Nguyen; Erica Warlick; Jenny N Poynter
Journal:  Cancer Causes Control       Date:  2021-01-04       Impact factor: 2.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.